Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.

被引：0
|
作者：
Font, A
Esteban, E
Carles, J
Climent, MA
Gonzalez-Larriba, JL
Berrocal, A
Bellmunt, J
Garcia-Ribas, I
Marfa, X
Fabregat, X
机构：
[1] Hosp Germans Trias & Pujol, Badalona, Spain
[2] Hosp Gen Asturias, E-33006 Oviedo, Spain
[3] Hosp Mar, Barcelona, Spain
[4] Inst Valenciano Oncol, Valencia, Spain
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Gen Hosp, Valencia, Spain
[7] Hosp Gen Valle Hebron, Barcelona, Spain
[8] Eli Lilly & Co, Alcobendas, Spain
[9] Sanofi Sinthelabo, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4544
引用
收藏
页码：392S / 392S
页数：1
相关论文
共 50 条
  • [1] Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
    Carles, J.
    Esteban, E.
    Climent, M.
    Font, A.
    Gonzalez-Larriba, J. L.
    Berrocal, A.
    Garcia-Ribas, I.
    Marfa, X.
    Fabregat, X.
    Albanell, J.
    Bellmunt, J.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (08) : 1359 - 1362
  • [2] Gemcitabine and oxaliplatin combination:: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
    Carles, Joan
    Esteban, E.
    Climent, M.
    Font, A.
    Gonzalez-Larriba, J. L.
    Berrocal, A.
    Fabregat, X.
    Albanell, J.
    Bellmunt, J.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 151 - 152
  • [3] Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer.
    Song, Eun-Kee
    Han, Hye-Suk
    Lee, Ki Hyeong
    Lee, Kyu Taek
    Bae, Sang Byung
    Kim, Han Jo
    Kim, Samyong
    Yun, Hwan Jung
    Cho, Sang Hoe
    Shim, Hyun-Jeong
    Yhim, Ho-Young
    Leo, Na-Ri
    Joon, So Yoon
    Yim, Chang-Yeoi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.
    Lim, Sung Hee
    Yun, Jina
    Lee, Min-Young
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Hong, Dae Sik
    Choi, Hyun Jong
    Moon, Jong Ho
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] EXIBIT:: An international multicenter phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer.
    André, T.
    Reyes-Vidal, J. M.
    Fartoux, L.
    Ross, P.
    Leslie, M.
    Rosmorduc, O.
    Clemens, M. R.
    Louvet, C.
    Perez, N.
    Scheithauer, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 211S - 211S
  • [6] Phase two clinical trial of combination oxaliplatin, irinotecan, and cetuximab for patients with locally advanced or metastatic pancreatic cancer.
    Abdou, Yara
    Friend, Sarah Cooke
    Patt, Yehuda Z.
    Gan, Christine
    Lee, Fa-Chyi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
    Kaufman, DS
    Carducci, MA
    Kuzel, TM
    Todd, MB
    Oh, WK
    Smith, MR
    Ye, ZS
    Nicol, SJ
    Stadle, WM
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (05) : 393 - 397
  • [8] Oxaliplatin and Irinotecan in advanced gastric cancer.: A multicenter phase II trial
    Woell, E.
    Eisterer, W.
    Hilbe, W.
    Kuehr, T.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Baldinger, C.
    Thaler, J.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [9] Phase II trial of gemcitabine plus cisplatin plus ipilimumab in patients with metastatic urothelial cancer.
    Galsky, Matt D.
    Hahn, Noah M.
    Albany, Costantine
    Fleming, Mark T.
    Starodub, Alexander
    Twardowski, Przemyslaw
    Pal, Sumanta K.
    Hauke, Ralph J.
    Sonpavde, Guru
    Oh, William K.
    Bhardwaj, Nina
    Gnjatic, Sacha
    Kim-Schulze, Seunghee
    Liu, Ziyue
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [10] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
    Brodowicz, T
    Wolfram, RM
    Köstler, WJ
    Tomek, S
    Vaclavik, I
    Steger, GG
    Teleky, B
    Függer, R
    Jakesz, R
    Zielinski, CC
    [J]. ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
12345